PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35180545-6	2022	In this paper, a reliable resolution and determination method was presented using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for fourteen enantiomers of seven beta2-agonist racemates, clenbuterol (CLE), salbutamol (SAL), cimaterol (CIM), terbutaline (TER), clorprenaline (CLO), tulobuterol (TUL), penbuterol (PEN) in pork, beef, and lamb muscle samples.	Terbutaline	253-264	ATPase H+ transporting V0 subunit a2	Homo sapiens	174-179	
35180545-6	2022	In this paper, a reliable resolution and determination method was presented using liquid chromatography-tandem mass spectrometry (LC-MS/MS) for fourteen enantiomers of seven beta2-agonist racemates, clenbuterol (CLE), salbutamol (SAL), cimaterol (CIM), terbutaline (TER), clorprenaline (CLO), tulobuterol (TUL), penbuterol (PEN) in pork, beef, and lamb muscle samples.	Terbutaline	266-269	ATPase H+ transporting V0 subunit a2	Homo sapiens	174-179	
33181580-2	2021	The aim of this study was to test if the beta2-agonist terbutaline relieves painful polyneuropathy.	Terbutaline	55-66	ATPase H+ transporting V0 subunit a2	Homo sapiens	41-46	
33132694-1	2020	Introduction: Salbutamol and terbutaline are short-acting beta2 adrenergic agonists that produce bronchial smooth muscle relaxation and are widely used in obstructive pulmonary diseases.	Terbutaline	29-40	ATPase H+ transporting V0 subunit a2	Homo sapiens	58-63	
33132694-11	2020	Conclusion: Salbutamol and terbutaline are generally well-tolerated beta2 adrenergic agonists.	Terbutaline	27-38	ATPase H+ transporting V0 subunit a2	Homo sapiens	68-73	
31442335-2	2019	Herein, we investigated beta2 -adrenergic-induced changes in V    O2max , leg and arm composition, and muscle content of oxidative enzymes in response to treatment with the selective beta2 -adrenergic agonist terbutaline with and without concurrent resistance training in young men.	Terbutaline	209-220	ATPase H+ transporting V0 subunit a2	Homo sapiens	24-29	
31442335-2	2019	Herein, we investigated beta2 -adrenergic-induced changes in V    O2max , leg and arm composition, and muscle content of oxidative enzymes in response to treatment with the selective beta2 -adrenergic agonist terbutaline with and without concurrent resistance training in young men.	Terbutaline	209-220	ATPase H+ transporting V0 subunit a2	Homo sapiens	183-188	
31442335-9	2019	Accordingly, chronic treatment with the selective beta2 -adrenergic agonist terbutaline may negatively affect V    O2max and iPPO in relative terms, but not in absolute.	Terbutaline	76-87	ATPase H+ transporting V0 subunit a2	Homo sapiens	50-55